Скачать или смотреть Debate Session (01-02-2026): Prioritize Gene-Editing for Next-Gen Antibiotics in Africa? | G9—Aff

Welcome to the Policy Advocacy in Genetics and Genomics course debate session, hosted by the Pan-African PGS Education and Research Initiative (PAPERI).

This video features the Affirmative Team from Group 9, supporting the motion:
“Should the use of gene-editing technologies (e.g., CRISPR-Cas9) to develop next-generation antibiotics be a public investment priority in Africa?”

The team argues that Africa should invest in gene-editing for antibiotic innovation because:
✅ AMR is rising rapidly across the continent, demanding breakthrough solutions.
✅ CRISPR and gene-editing tools enable precision engineering of powerful new antimicrobial agents.
✅ Investing now positions Africa as a global leader, not a late adopter.
✅ Locally driven antibiotic innovation enhances sovereignty and reduces dependency on external markets.
✅ Public sector investment ensures equity, access, and public-good–oriented development.

🎥 Watch the Negative Team’s counterarguments here: [   • Debate Session (01-02-2026): Prioritize Ge...  ]

📌 Reflect on whether investing in cutting-edge antibiotic innovation is Africa’s best strategy in the fight against AMR — or whether other priorities must come first.

#CRISPR #GeneEditing #NextGenAntibiotics #AMR #PAPERI #PolicyDebate #GenomicsForHealth #AfricaScience #HealthSecurity